Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-678-8 | CAS number: 109-53-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.2 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 25
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 105 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Not necessary; repeated dose toxicity study by inhalation is available.
- AF for dose response relationship:
- 1
- Justification:
- Default value
- AF for differences in duration of exposure:
- 2
- Justification:
- Default AF for time extrapolation from subchronic to chronic exposure
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Allometric scaling was already considered when calculating the starting point (NOAEC)
- AF for other interspecies differences:
- 2.5
- Justification:
- Default AF for other interspecies differences
- AF for intraspecies differences:
- 5
- Justification:
- Default AF for exposure group "worker"
- AF for the quality of the whole database:
- 1
- Justification:
- Quality of whole data base is considered to be sufficient and uncritical
- AF for remaining uncertainties:
- 1
- Justification:
- Default value
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 8.4 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 12.5
- Dose descriptor:
- NOAEC
- AF for dose response relationship:
- 1
- Justification:
- Default value
- AF for differences in duration of exposure:
- 1
- Justification:
- Not applicable in case of local effects
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Allometric scaling was already considered when calculating the starting point (NOAEC)
- AF for other interspecies differences:
- 2.5
- Justification:
- Default AF for other interspecies differences
- AF for intraspecies differences:
- 5
- Justification:
- Default AF for exposure group "worker"
- AF for the quality of the whole database:
- 1
- Justification:
- Quality of whole data base is considered to be sufficient and uncritical
- AF for remaining uncertainties:
- 1
- Justification:
- Default value
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.4 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 25
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 60.3 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
No repeated dose toxicity study with dermal application is available. Therefore an inhalation-to-dermal extrapolation is done.
- AF for dose response relationship:
- 1
- Justification:
- Default value
- AF for differences in duration of exposure:
- 2
- Justification:
- Default value for time extrapolation from sub-chronic to chronic study
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Allometric scaling was already considered due to the starting point (NOAEC)
- AF for other interspecies differences:
- 2.5
- Justification:
- Default AF for other interspecies differences
- AF for intraspecies differences:
- 5
- Justification:
- Default AF for exposure group "worker"
- AF for the quality of the whole database:
- 1
- Justification:
- Quality of whole data base is considered to be sufficient and uncritical
- AF for remaining uncertainties:
- 1
- Justification:
- Default value
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
Derivation of worker DNELs for isobutyl vinyl ether (IBVE)
General remarks
A category aproach (OECD SIDS 2006) is available for vinyl ethers (report included in IUCLID chapter 13): methyl vinyl ether (MVE; CAS 107-25-5), ethyl vinyl ether (EVE, CAS 109-92-2), and isobutyl vinyl ether (IBVE, CAS 109-53-5).
The oral LD50 of IBVE in rats was 13100 mg/kg bw. The dermal LD50 in rabbits was 15400 mg/kg bw. In acute inhalation studies in rats the LC50 (4 h) was > 21000 mg/m³.
IBVE was a skin irritant in rabbits after 2 or 24 hours of occlusive treatment. Undiluted IBVE was only slightly irritant to the rabbit eye.
After subchronic inhalation exposure to IBVE in rats local effects in the nasal cavity were found as well as adapative effects in liver and kidney (increased metabolism of the test substance; no histopathological effects) at a concentration of >= 500 ppm (2080 mg/m³); the NOAEC was 50 ppm (208 mg/m³).
No mutagenic activity was found in in vitro studies with bacterial or mammalian cells as well as no clastogenic or aneugenic activity in mammalian cells. Data on genotoxicity in vivo or carcinogenic activity are not available.
Reproductive toxicity (reduced live birth index in F1 rats) after inhalation exposure to IBVE was reported in a Guideline study according to OECD TG422 at 2000 ppm (8300 mg/m³) in the presence of maternal toxicity like clinical signs and reduced body weight; the NOAEC for reproductive toxicity is 500 ppm (2080 mg/m³).
DNEL acute toxicity
IBVE is not classified for acute toxicity. Thus, no DNELs for acute toxicity were considered.
Worker-DNEL long-term for inhalation route-systemic
Relevant dose-descriptor for the endpoint concerned: NOAEC systemic 208 mg/m³, sub-chronic inhalation study in rats with IBVE (BASF 2004).
Correction of starting point
No difference in bioavailability between humans and rats assumed.
Same route of exposure.
Differences in exposure conditions (6 h/day in rat inhalation study versus occupational exposure 8 h/day): factor 6/8 = 0.75
Differences in respiratory volumes between experimental animals (at rest) and humans (light activity): respiratory volume in humans during 8 h at rest is 6.7 m³ versus 10 m³ for 8 h at light activity for workers; factor 6.7/10 = 0.67
NOAEC x 0.75 x 0.67 = 208 mg/m³ x 0.5025 = 105 mg/m³
Assessment factors relating to the extrapolation procedure
Interspecies differences: default factor of 2.5.
Intraspecies differences: default assessment factor of 5 for workers.
Differences in duration of exposure: sub-chronic data used, assessment factor 2.
Issues related to dose-response: the starting point for the DNEL calculation is a NOAEC; therefore a default assessment factor of 1 is used.
Quality of whole database: sufficient; no additional assessment factor.
Overall
assessment factor: 2.5 x 5 x 2= 25
DNEL worker chronic inhalation systemic = 105 mg/m³ : 25 = 4.2 mg/m³
Worker-DNEL long-term for inhalation route-local
Relevant dose-descriptor for the
endpoint concerned:
NOAEC
= 208 mg/m³ for local effects in the upper respiratory tract of rats
after sub-chronic inhalation exposure to IBVE (BASF 2004).
Correction of starting point
No difference in bioavailability between humans and rats assumed.
Same route of exposure in rats and humans; no correction necessary.
Correction of exposure conditions (occupational exposure duration 8 h/day versus 6 h/day in the rat study and differences in respiratory volume in 8 h at rest [6.7 m³) and at light work [10 m³]). Factor 6/8 = 0.75 (exposure duration) and factor 6.7/10 = 0.67 (respiratory volume).
NOAEC 208 mg/m³ x 0.75 x 0.67 = 105 mg/m³ (corrected starting point)
Assessment factors relating to the extrapolation procedure
Interspecies differences: human versus rat; additional factor of 2.5 for ‘remaining differences’ between rat and humans.
Intraspecies differences: default assessment factor of 5 for workers.
Differences in duration of exposure: not applicable for local effects.
Issues related to dose-response: the starting point for the DNEL calculation is a NOAEC; therefore an assessment factor of 1 is used.
Quality of whole database: sufficient; assessment factor 1.
Overall
assessment factor: 2.5 x 5 = 12.5
DNEL worker chronic inhalation local = 105 mg/m³ : 12.5 = 8.4 mg/m³
Worker-DNEL long-term for dermal route-systemic
Relevant dose-descriptor for the endpoint concerned: NOAEC systemic 208 mg/m³, sub-chronic inhalation study in rats with IBVE (BASF 2004).
This point of departure was modified to get the corrected starting point for DNEL derivation based on a route-to-route (inhal. to dermal) extrapolation. A corrected dermal NOAEL (NOAELcorr) was calculated using the default respiratory volume reflecting the daily exposure period of the rats during the study (6 hours):
NOAEL (dermal-rat) =NOAEC x (sRVrat) x (ABSinhal-rat/ABSdermal-human)=208 mg/m³ x (0.29 m³/kg bw/d) x (1/1) = 60.3 mg/kg bw/d
- Standard dose descriptor (NOAEC): 208 mg/m³
- Standard respiratory volume of the rat (sRVrat) for 6 hours: 0.29 m³/kg bw/d
- Inhalation absorption of the rat/dermal absorption of humans (ABSinhal-rat)/ABSdermal-human): 1/1
Use of assessment factors: 25
Interspecies AF: 1 (allometric scaling already considered due to starting point (NOAEC))
Interspecies AF, remaining differences: 2.5
Intraspecies AF (worker): 5
Exposure duration AF: 2 (sub-chronic to chronic study)
Remaining uncertainties AF: 1
In conclusion, long-term systemic dermal DNEL, workers was calculated to be 2.4 mg/kg bw/d.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
Derivation of consumer DNELs for isobutyl vinyl ether (IBVE)
General remarks:
IBVE is practically exclusively used as an intermediate in the manufacture of vinyl ether polymers and co-polymers. Further to its use as industrial intermediate in the manufacture of pharmaceuticals and dyes, IBVE is also used as intermediate in the manufacture of polymers and co-polymers for use as food packaging materials and adhesives. Hence, consumer exposure to residual IBVE may occur through the use of these products. However, consumer exposure to residual IBVE is considered to be negligible, since marketed vinyl ether polymers and co-polymers are heat-treated and potentially existing residual IBVE is evaporating during this process. In polymers and co-polymers, IBVE is in a chemically covalently bound form and does not degrade to monomers under use or waste stage.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.